Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (unaudited) (Parenthetical)

v3.23.3
Condensed Consolidated Balance Sheets (unaudited) (Parenthetical) - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Debt Instrument [Line Items]    
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 500,000,000 500,000,000
Common stock, shares issued 388,975,605 376,074,096
Common stock, shares outstanding 388,975,605 376,074,096
Convertible Notes Payable [Member]    
Debt Instrument [Line Items]    
Discounts on convertible notes payable $ 118,000 $ 140,000
Convertible notes in default $ 1,977,000 $ 1,730,000